ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Abroad (travel likely)Recruiting

Conditions

Myasthenia Gravis · MG · gMG · Generalized Myasthenia Gravis · Generalized Myasthenia Gravis (gMG) · AChR-Ab Seropositive Generalized Myasthenia Gravis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Profound Research LLC - Carlsbad, Carlsbad, California, United States
Contact: Study coordinator (Gregory Sahagian, MD) · lupe@profoundresearch.com · 760-732-0557
Visionary Investigators Network, Miami, Florida, United States
Contact: Study coordinator (Andrew Lerman, MD) · alerman@fcneurology.net · 786-655-8010
University of South Florida, Tampa, Florida, United States
Contact: Study coordinator (Tuan Vu, MD) · tvu6@usf.edu · (813) 974-9413
Erlanger Health System, Columbia, Maryland, United States
Contact: Study coordinator (Joshua Alpers, MD) · clinicaltrials@argenx.com · 857-350-4834
Henry Ford Health System, Detroit, Michigan, United States
Dent Neurologic Institute - Amherst, Amherst, New York, United States
Contact: Study coordinator (Luisa Rojas Estupinan, MD) · aemborsky@dentinstitute.com · 716-250-2000
Duke Early Phase Clinical Research Unit - PPDS, Durham, North Carolina, United States
Ohio State Martha Morehouse Outpatient Care, Columbus, Ohio, United States
Contact: Study coordinator (Miriam Freimer, MD) · Mariam.Freimer@osumc.edu · 614-293-4969
Erlanger Health System, Chattanooga, Tennessee, United States
Contact: Study coordinator (Joshua Alpers, MD) · joshua.alpers@erlanger.org · 423-778-3900
National Neuromuscular Research Institute, Austin, Texas, United States
Contact: Study coordinator (Yessar Hussain, MD) · marisol@austinneuromuscle.com · 512-920-0140
University of Texas- San Antonio - Health Science Center - PPDS, San Antonio, Texas, United States
Contact: Study coordinator (Ratna Bhavaraju-Sanka, MD) · BhavarajuSan@uthscsa.edu · 210-567-8229
UZ Leuven - PPDS, Leuven, Belgium
Contact: Study coordinator (Kristl Claeys, MD) · kristi.claeys@uzleuven.be · +3216344278
ASST Papa Giovanni XXIII - Ospedale Papa Giovanni XXIII, Bergamo, Lombardy, Italy
Contact: Study coordinator (Giorgia Camera, MD) · clinicaltrials@argenx.com · 857-350-4834
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Lombardy, Italy
MICS Centrum Medyczne Bydgoszcz, Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Contact: Study coordinator (Lukasz Rzepinski, MD) · lukasz.rzepinski@mics.medicover.com · +48523401414
Krakowska Akademia Neurologii Sp. z o.o., Krakow, Lesser Poland Voivodeship, Poland
Contact: Study coordinator (Andrzej Szczudlik, MD) · andrzej.szczudlik@neurologia.org.pl · +48602628121
Centrum Medyczne Neurologia Slaska, Katowice, Silesian Voivodeship, Poland
Contact: Study coordinator (Marek Smilowski, MD) · marek.smilowski@neurologiaslaska.pl · +48500282494
Hospital Regional Universitario de Malaga - Hospital General, Málaga, Malaga, Spain
Contact: Study coordinator (Guillermina García Martín, MD) · ecortes@santpau.cat · +34935537115

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Generalized Myasthenia Gravis · gMG

Abroad (travel likely)RecruitingPHASE3

Washington D.C., United States · Norfolk, United States

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Chicago, United States · Chapel Hill, United States

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Myasthenia Gravis

Abroad (travel likely)Recruiting

San Francisco, United States · Boca Raton, United States

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

Myasthenia Gravis · CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Abroad (travel likely)Recruiting

Morgantown, United States · Bochum, Germany